| Mrs Emily M Cottrell, FNP-BC | |
|
4 Memorial Dr Ste 230, Alton, IL 62002-6704 | |
| (618) 433-6750 | |
| Not Available |
| Full Name | Mrs Emily M Cottrell |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 4 Memorial Dr Ste 230, Alton, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295262459 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 209015999 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Gateway Regional Medical Center | Granite city, IL | Hospital |
| Anderson Hospital | Maryville, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fairview Heights Medical Group Sc | 6800784083 | 342 |
News Archive
In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will present findings that show that by performing an amniotomy on first time mothers in situations when labor has to be induced, that delivery time can be shortened by more than 10 percent.
Talecris Biotherapeutics Holdings Corp. today announced that it has commenced an offering through a private placement of $550 million aggregate principal amount of senior notes due 2016 (the "Notes"). Talecris intends to use the proceeds from the offering to repay its First and Second Lien Term Loans, repay a portion of borrowings under its Revolving Credit Facility, and to pay related fees and expenses.
Overexpression of PEA-15, which binds and drags an oncoprotein out of the cell nucleus where it fuels cancer growth, steeply reduced breast cancer tumors in a preclinical experiment, researchers at The University of Texas M. D. Anderson Cancer Center reported at the 100th annual meeting of the American Association for Cancer Research.
An international team involving dozens of stakeholders from patients and policy makers to payers and government agencies are getting together to set how gene therapies in hemophilia should be measured for effectiveness.
› Verified 4 days ago
| Entity Name | Fairview Heights Medical Group Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679503668 PECOS PAC ID: 6800784083 Enrollment ID: O20040309000650 |
News Archive
In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will present findings that show that by performing an amniotomy on first time mothers in situations when labor has to be induced, that delivery time can be shortened by more than 10 percent.
Talecris Biotherapeutics Holdings Corp. today announced that it has commenced an offering through a private placement of $550 million aggregate principal amount of senior notes due 2016 (the "Notes"). Talecris intends to use the proceeds from the offering to repay its First and Second Lien Term Loans, repay a portion of borrowings under its Revolving Credit Facility, and to pay related fees and expenses.
Overexpression of PEA-15, which binds and drags an oncoprotein out of the cell nucleus where it fuels cancer growth, steeply reduced breast cancer tumors in a preclinical experiment, researchers at The University of Texas M. D. Anderson Cancer Center reported at the 100th annual meeting of the American Association for Cancer Research.
An international team involving dozens of stakeholders from patients and policy makers to payers and government agencies are getting together to set how gene therapies in hemophilia should be measured for effectiveness.
› Verified 4 days ago
| Entity Name | Granite City Clinic Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255387957 PECOS PAC ID: 6406747906 Enrollment ID: O20040323001668 |
News Archive
In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will present findings that show that by performing an amniotomy on first time mothers in situations when labor has to be induced, that delivery time can be shortened by more than 10 percent.
Talecris Biotherapeutics Holdings Corp. today announced that it has commenced an offering through a private placement of $550 million aggregate principal amount of senior notes due 2016 (the "Notes"). Talecris intends to use the proceeds from the offering to repay its First and Second Lien Term Loans, repay a portion of borrowings under its Revolving Credit Facility, and to pay related fees and expenses.
Overexpression of PEA-15, which binds and drags an oncoprotein out of the cell nucleus where it fuels cancer growth, steeply reduced breast cancer tumors in a preclinical experiment, researchers at The University of Texas M. D. Anderson Cancer Center reported at the 100th annual meeting of the American Association for Cancer Research.
An international team involving dozens of stakeholders from patients and policy makers to payers and government agencies are getting together to set how gene therapies in hemophilia should be measured for effectiveness.
› Verified 4 days ago
| Entity Name | Heartland Rural Healthcare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275166134 PECOS PAC ID: 3072513043 Enrollment ID: O20061226000075 |
News Archive
In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will present findings that show that by performing an amniotomy on first time mothers in situations when labor has to be induced, that delivery time can be shortened by more than 10 percent.
Talecris Biotherapeutics Holdings Corp. today announced that it has commenced an offering through a private placement of $550 million aggregate principal amount of senior notes due 2016 (the "Notes"). Talecris intends to use the proceeds from the offering to repay its First and Second Lien Term Loans, repay a portion of borrowings under its Revolving Credit Facility, and to pay related fees and expenses.
Overexpression of PEA-15, which binds and drags an oncoprotein out of the cell nucleus where it fuels cancer growth, steeply reduced breast cancer tumors in a preclinical experiment, researchers at The University of Texas M. D. Anderson Cancer Center reported at the 100th annual meeting of the American Association for Cancer Research.
An international team involving dozens of stakeholders from patients and policy makers to payers and government agencies are getting together to set how gene therapies in hemophilia should be measured for effectiveness.
› Verified 4 days ago
| Entity Name | Ahs Il Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659098101 PECOS PAC ID: 5496111676 Enrollment ID: O20230512001300 |
News Archive
In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will present findings that show that by performing an amniotomy on first time mothers in situations when labor has to be induced, that delivery time can be shortened by more than 10 percent.
Talecris Biotherapeutics Holdings Corp. today announced that it has commenced an offering through a private placement of $550 million aggregate principal amount of senior notes due 2016 (the "Notes"). Talecris intends to use the proceeds from the offering to repay its First and Second Lien Term Loans, repay a portion of borrowings under its Revolving Credit Facility, and to pay related fees and expenses.
Overexpression of PEA-15, which binds and drags an oncoprotein out of the cell nucleus where it fuels cancer growth, steeply reduced breast cancer tumors in a preclinical experiment, researchers at The University of Texas M. D. Anderson Cancer Center reported at the 100th annual meeting of the American Association for Cancer Research.
An international team involving dozens of stakeholders from patients and policy makers to payers and government agencies are getting together to set how gene therapies in hemophilia should be measured for effectiveness.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Emily M Cottrell, FNP-BC 4 Memorial Dr Ste 230, Alton, IL 62002-6704 Ph: (618) 433-6750 | Mrs Emily M Cottrell, FNP-BC 4 Memorial Dr Ste 230, Alton, IL 62002-6704 Ph: (618) 433-6750 |
News Archive
In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will present findings that show that by performing an amniotomy on first time mothers in situations when labor has to be induced, that delivery time can be shortened by more than 10 percent.
Talecris Biotherapeutics Holdings Corp. today announced that it has commenced an offering through a private placement of $550 million aggregate principal amount of senior notes due 2016 (the "Notes"). Talecris intends to use the proceeds from the offering to repay its First and Second Lien Term Loans, repay a portion of borrowings under its Revolving Credit Facility, and to pay related fees and expenses.
Overexpression of PEA-15, which binds and drags an oncoprotein out of the cell nucleus where it fuels cancer growth, steeply reduced breast cancer tumors in a preclinical experiment, researchers at The University of Texas M. D. Anderson Cancer Center reported at the 100th annual meeting of the American Association for Cancer Research.
An international team involving dozens of stakeholders from patients and policy makers to payers and government agencies are getting together to set how gene therapies in hemophilia should be measured for effectiveness.
› Verified 4 days ago
Mrs. Misty D Biciocchi, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4 Memorial Dr, Ste 134, Alton, IL 62002 Phone: 618-607-1340 Fax: 618-622-9724 | |
Lee A Tardino, MSN ANP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4 Memorial Dr Ste 210, Alton, IL 62002 Phone: 618-463-5905 Fax: 618-463-5935 | |
Jodi R Lutz, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1650 Washington Ave, Alton, IL 62002 Phone: 314-687-2735 | |
Lisa K James, ANP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4 Memorial Dr Ste 230, Alton, IL 62002 Phone: 618-433-6170 | |
Laura L Brandenburg, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4 Memorial Dr, Ste 230b, Alton, IL 62002 Phone: 618-463-7777 Fax: 618-463-7767 | |
Kelsey M Beard, FNP-BC, DNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4 Memorial Dr Ste 210, Alton, IL 62002 Phone: 618-463-5905 Fax: 618-463-5035 | |
Anissa Fay Washington, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Memorial Dr, Alton, IL 62002 Phone: 618-463-7300 |